Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Validation of extracellular ligand-receptor interactions by Flow-TriCEPS.

Lopez-Garcia LA, Demiray L, Ruch-Marder S, Hopp AK, Hottiger MO, Helbling PM, Pavlou MP.

BMC Res Notes. 2018 Dec 5;11(1):863. doi: 10.1186/s13104-018-3974-5.

2.

Dynamics of Protein Expression Reveals Primary Targets and Secondary Messengers of Estrogen Receptor Alpha Signaling in MCF-7 Breast Cancer Cells.

Drabovich AP, Pavlou MP, Schiza C, Diamandis EP.

Mol Cell Proteomics. 2016 Jun;15(6):2093-107. doi: 10.1074/mcp.M115.057257. Epub 2016 Apr 11.

3.

Integrating meta-analysis of microarray data and targeted proteomics for biomarker identification: application in breast cancer.

Pavlou MP, Dimitromanolakis A, Martinez-Morillo E, Smid M, Foekens JA, Diamandis EP.

J Proteome Res. 2014 Jun 6;13(6):2897-909. doi: 10.1021/pr500352e. Epub 2014 May 14.

PMID:
24799281
4.

In-depth proteomic delineation of the colorectal cancer exoproteome: Mechanistic insight and identification of potential biomarkers.

Karagiannis GS, Pavlou MP, Saraon P, Musrap N, Xie A, Batruch I, Prassas I, Dimitromanolakis A, Petraki C, Diamandis EP.

J Proteomics. 2014 May 30;103:121-36. doi: 10.1016/j.jprot.2014.03.018. Epub 2014 Mar 27.

PMID:
24681409
5.

Coupling proteomics and transcriptomics in the quest of subtype-specific proteins in breast cancer.

Pavlou MP, Dimitromanolakis A, Diamandis EP.

Proteomics. 2013 Apr;13(7):1083-95. doi: 10.1002/pmic.201200526. Epub 2013 Feb 25.

PMID:
23386393
6.

The long journey of cancer biomarkers from the bench to the clinic.

Pavlou MP, Diamandis EP, Blasutig IM.

Clin Chem. 2013 Jan;59(1):147-57. doi: 10.1373/clinchem.2012.184614. Epub 2012 Sep 27. Review.

7.

Quantitative analysis of energy metabolic pathways in MCF-7 breast cancer cells by selected reaction monitoring assay.

Drabovich AP, Pavlou MP, Dimitromanolakis A, Diamandis EP.

Mol Cell Proteomics. 2012 Aug;11(8):422-34. doi: 10.1074/mcp.M111.015214. Epub 2012 Apr 25.

8.

Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology.

Karagiannis GS, Pavlou MP, Diamandis EP.

Mol Oncol. 2010 Dec;4(6):496-510. doi: 10.1016/j.molonc.2010.09.001. Epub 2010 Sep 16. Review.

9.

The cancer cell secretome: a good source for discovering biomarkers?

Pavlou MP, Diamandis EP.

J Proteomics. 2010 Sep 10;73(10):1896-906. doi: 10.1016/j.jprot.2010.04.003. Epub 2010 Apr 12. Review.

PMID:
20394844
10.

Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer.

Kulasingam V, Pavlou MP, Diamandis EP.

Nat Rev Cancer. 2010 May;10(5):371-8. doi: 10.1038/nrc2831. Epub 2010 Apr 12. Review.

PMID:
20383179
11.

Nipple aspirate fluid proteome of healthy females and patients with breast cancer.

Pavlou MP, Kulasingam V, Sauter ER, Kliethermes B, Diamandis EP.

Clin Chem. 2010 May;56(5):848-55. doi: 10.1373/clinchem.2009.136283. Epub 2010 Mar 26.

12.

Self-neglect in older adults: a primer for clinicians.

Pavlou MP, Lachs MS.

J Gen Intern Med. 2008 Nov;23(11):1841-6. doi: 10.1007/s11606-008-0717-7. Epub 2008 Jul 23.

13.

Could self-neglect in older adults be a geriatric syndrome?

Pavlou MP, Lachs MS.

J Am Geriatr Soc. 2006 May;54(5):831-42. Review.

PMID:
16696752

Supplemental Content

Loading ...
Support Center